Aptorum Group Limited (APM)
NASDAQ·Healthcare·Biotechnology
$0.88
-1.73%
Mkt Cap $5.08M
No analyst coverage available
We don't have analyst ratings or price target data for Aptorum Group Limited yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.